REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Icosan Internacional Ltda (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Icosan Internacional Ltda Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Fabricacion compraventa distribucion importacion y expórtacion de toda clase de tecnologias elementos, equiposd e insumos medicos y hospitalarios reactivos para diagnostico productos farmaceuticos, va.

Headquarters
Carrera 20 # 169 25
Bogota D.C.; Bogota D.C; Postal Code: 1024

Contact Details: Purchase the Icosan Internacional Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Icosan Internacional Ltda report to view the information.
Outstanding Shares:
Purchase the Icosan Internacional Ltda report to view the information.
Incorporation Date:
July 17, 1995
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Icosan Internacional Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
18.55%▲
Total operating revenue
18.55%▲
Operating profit (EBIT)
67.45%▲
Net Profit (Loss) for the Period
2495.66%▲
Total assets
57.87%▲
Total equity
29.51%▲
Operating Profit Margin (ROS)
5.47%▲
Net Profit Margin
9.33%▲
Return on Equity (ROE)
21.65%▲
Quick Ratio
-1.71%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo